BACKGROUND
Propofol is widely used for sedation in the intensive care unit (ICU), but its use may be limited by cardiovascular depression, hypertriglyceridemia, and propofol infusion syndrome. Remimazolam has emerged as a potential alternative to propofol, with rapid metabolism, predictable recovery, and flumazenil rev...
Shunichi Nakahara, A. Velarde Pineda, C. A. Romero Bonifaz et al.· Journal of critical care· 0 citations
INTRODUCTION
Older adults face an increased risk of influenza-related complications, particularly cardiovascular (CV) events. The comparative effectiveness of high-dose inactivated influenza vaccine (HD-IIV) versus standard-dose inactivated influenza vaccine (SD-IIV) for these outcomes remains uncertain.
METHODS
Data...
Larissa Araújo de Lucena, B. Hakkeem, N. Schettino Samad et al.· American Journal of Preventi...· 0 citations
BACKGROUND
Remimazolam is a novel ultra-short-acting intravenous benzodiazepine, while sevoflurane is a widely used inhalational anaesthetic for general anaesthesia (GA). Both agents are associated with risks of haemodynamic instability and postoperative nausea and vomiting (PONV), which can affect patient safety and r...
L. Takayama, Kevlin de Souza, David Abraham Batista da Hora et al.· European Journal of Anaesthe...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.